Updates

August 27, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Business Responsibility and Sustainability Report of the HealthCare Global Enterprises Limited (“the Company”) for Financial Year 2025-26. Stock Code : BSE – 539787, NSE – HCG Reference : Regulation 30, 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023, and last updated on January 30, 2026 (“SEBI Circular”) Pursuant to Regulation 34(2)(f) of the Listing Regulations, please find enclosed herewith Business Responsibility and Sustainability Report (“BRSR”) for the financial year ended March 31, 2026, which forms part of the Integrated Annual Report of the Company. The aforesaid document is also available on the website of the Company and can be accessed at https://www.hcgoncology.com/annual-reports/. You are requested to take the information on record. Thanking You, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary and Compliance Officer. Encl: a/a HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag Annual Report 2025-26 Business Responsibility & Sustainability Report Corporate Overview Statutory Reports Financial Statements SECTION A: GENERAL DISCLOSURES I Details of the listed entity 1. Corporate Identity Number (CIN) of the Listed Entity : L15200KA1998PLC023489 2. Name of the Listed Entity : HealthCare Global Enterprises Limited 3. Year of incorporation : 12/03/1998 4. Registered office address : HCG Towers, No.8, P. Kalinga Rao Road, Sampangi Rama Nagar, Bangalore, Karnataka, India – 560027 5. Corporate address : No 3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bangalore, Karnataka, India - 560027 6. E-mail : investors@hcgel.com 7. Telephone : +91-80-4660 7700 8. Website : https://www.hcgoncology.com/ 9. Financial year for which reporting is being done : FY 2025-26 10. Name of the Stock Exchange(s) where shares are listed : BSE Ltd. and National Stock Exchange of India Ltd. (NSE) 11. Paid-up Capital : INR 1,49,30,22,030 12. Name and contact details (telephone, email address) of : Sunu Manuel-Company Secretary, the person who may be contacted in case of any queries investors@hcgel.com, on the BRSR report +91-80-4660 7700 13. Reporting boundary : Consolidated1 14. Name of assurance provider : NA 15. Type of assurance obtained : NA II. Products/services 16. Details of business activities (accounting for 90% of the turnover): S. % of Turnover Description of Main Activity Description of Business Activity No. of the entity 1. Medical and Healthcare Medical and Healthcare 100% 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): S. % of total Product/Service NIC Code No. revenue contributed 1. Medical and Healthcare 8610 99% III. Operations 18. Number of locations where plants and/or operations/offices of the entity are situated: Location Number of plants Number of offices Total National 44 4 48 International 1 3 4 Note: This represents units and offices managed by the Company and its subsidiaries, which include 21 Comprehensive Cancer Centres (2 centres in Vijayawada, Vadodara, Vishakhapatnam, Jaipur, Ahmedabad, Hubli and Nashik respectively) in India and 1 in Kenya; 3 multi-specialty hospitals (including Bhavnagar), 6 Day Care Clinics (Includes OPDs), 1 PET-CT and 1 Cyclotron facility located at Chennai and 6 fertility centres operating under the Milann brand. 1The Report covers all the Units operated by the Company and its subsidiaries. More details on the entities covered are provided as response to Q.8 (a) ‘Names of holding / subsidiary / associate companies / joint ventures. The reporting timeline for this Report is 01 April 2025 to 31 March 2026. For Advanced Molecular Imaging Limited, HealthCare Global (Kenya) Private Limited holds 50% of the share capital and the reporting timeline has been considered as January to December 2025. HealthCare Global Enterprises Limited 3 Annual Report 2025-26 19. Markets served by the entity: a. Number of locations2 Locations Number National (No. of States) * 10 International (No. of Countries) 1 * This excludes the Milann IVF unit at Chandigarh. Other than the IVF unit, HCG does not have any presence in Chandigarh. b. What is the contribution of exports as a percentage of the total turnover of the entity? The contribution of exports as a percentage of the total turnover for FY 2025-26 is 2.13 %.3 c. A brief on types of customers The Company provides comprehensive healthcare services to a diverse patient base, serving both insured and uninsured individuals across its network. By offering access to specialised healthcare through multiple payment channels, the Company strives to ensure that quality cancer care remains accessible to patients from varied socioeconomic backgrounds. Our patient mix includes individuals covered under private health insurance, self-paying patients and beneficiaries of several government-sponsored healthcare schemes. The Company is empanelled under various central and state government health programmes, including the Central Government Health Scheme (CGHS), the Ex-Servicemen Contributory Health Scheme (ECHS) and other state government healthcare initiatives, enabling eligible beneficiaries to access specialised oncology services across our network. In addition, the Company serves patients whose healthcare coverage is supported through social security programmes administered by international institutions and organisations, in accordance with the applicable empanelment arrangements. These associations further expand access to specialised cancer care for eligible patient populations. Through this diversified patient base and broad network of empanelments, the Company is able to extend advanced oncology services to a wide spectrum of patients while supporting greater accessibility to quality healthcare. This reflects our continued commitment to delivering patient-centred care and ensuring that specialised cancer treatment is available to those who need it through multiple healthcare financing mechanisms. IV. Employees 20. Details as at the end of Financial Year: a. Employees and workers (including differently abled): S. Male Female Particulars Total (A) No. No. (B) % (B / A) No. (C) % (C / A) EMPLOYEES 1. Permanent (D) 6,759 3,395 50% 3,364 50% 2. Other than Permanent (E) 1,596 914 57% 682 43% 3. Total employees (D + E) 8,355 4,309 52% 4,046 48% *The Company does not have any workers as defined in the BRSR Guidance Note. b. Differently abled Employees and workers: S. Male Female Particulars Total (A) No. No. (B) % (B / A) No. (C) % (C / A) DIFFERENTLY ABLED EMPLOYEES 1. Permanent (D) 2 1 50% 1 50% 2. Other than Permanent (E) 0 0 0% 0 0% 3. Total differently abled employees (D + E) 2 1 50% 1 50% * The Company does not have any workers as defined in the BRSR Guidance Note. 2 The Company provides services to patients from various states, including those who travel to HCG for specialized cancer care from different parts of the country. Moreover, HCG offers its services not only in Kenya but also to patients from other international regions such as Africa, the Middl [Showing first 8,000 characters — download PDF for full document]